« Back
Home /
Recombinant Human EG-VEGF/PROK1

Recombinant Human EG-VEGF/PROK1

Item no.	CS-CRV015C
Manufacturer	Cell Sciences
Amount	1.0 mg
Category	Oncology By Cell Type Carcinoma Peptides & Proteins Recombinant Proteins Cell Biology Cell Culture Cytokines Adenocarcinoma By Organ Bladder Cancer
Type	Proteins
Specific against	Human
Host	E.coli
Purity	97%) determined by: HPLC, Reducing and Non-reducing SDS-PAGE, UV spectroscopy at 280 nm
Sequence	AVITGACERD VQCGAGTCCA ISLWLRGLRM CTPLGREGEE CHPGSHKVPF FRKRKHHTCP CLPNLLCSRF PDGRYRCSMD LKNINF
ECLASS 10.1	32160409
ECLASS 11.0	32160409
UNSPSC	12352202
Alias	EMAP-II/AIMP1
Similar products	PRK1, EG-VEGF, PK1, EGVEGF, black mamba toxin-related protein, mambakine, UNQ600/PRO1186, prokineticin-1, endocrine-gland-derived vascular endothelial growth factor
Available
Biological Activity	The activity is determined by the dose-dependent proliferation of MIA PaCa-2 cells and is typically 1-4 ug/mL.
Description	Endocrine Gland-derived Vascular Endothelial Growth Factor (EG-VEGF) is an angiogenic growth factor specifically expressed in the ovaries, testis, adrenal and placental tissues. The identification of tissue-selective angiogenic factors raises the possibility that other secreted molecules in this class exist. EG-VEGF expression correlates with vascularity in polycystic ovary syndrome, a leading cause of infertility. Recombinant human EG-VEGF is a non-glycosylated protein, containing 86 amino acids.
Endotoxin Level	Measured by kinetic LAL analysis and is typically <= 1 EU/ug protein.
Formulation	Recombinant human EG-VEGF is lyophilized with no additives.
Molecular Weight	9.6 kDa
Reconstitution	Centrifuge vial prior to opening. When reconstituting the product, gently pipet and wash down the sides of the vial to ensure full recovery of the protein into solution. It is recommended to reconstitute the lyophilized product with sterile water at a concentration of 0.1 mg/mL, which can be further diluted into other aqueous solutions.
Storage and Stability	Lyophilized product is very stable at -20C. Reconstituted material should be aliquoted and frozen at -20C. It is recommended that a carrier protein (0.1% HSA or BSA) is added for long term storage. Avoid repeated freeze-thaw cycles.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.